ASCO

  1. RBx
    643 Posts.
    lightbulb Created with Sketch. 1002
    The title of the NOX presentation at ASCO is:
    A phase 1 study of NOX66 in combination with carboplatin in patients with end stage cancer

    Graham Kelly appears to think that the use of NOX66 plus chemotherapy has considerable commercial potential, but what would he know?

    We should find out just why he remains confident when the updated abstract is published on the Noxopharm website on its day of presentation.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
9.3¢
Change
-0.002(2.11%)
Mkt cap ! $27.17M
Open High Low Value Volume
9.4¢ 9.4¢ 9.3¢ $5.033K 54.05K

Buyers (Bids)

No. Vol. Price($)
1 5398 9.2¢
 

Sellers (Offers)

Price($) Vol. No.
9.4¢ 151194 1
View Market Depth
Last trade - 11.31am 16/09/2025 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.